title: Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.
authors.affiliation: Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey. tkutluk@tr.net
authors.forename: Tezer
authors.initials: T
authors.lastname: Kutluk
authors.forename: Ogün
authors.initials: O
authors.lastname: Kurne
authors.forename: Canan
authors.initials: C
authors.lastname: Akyüz
authors.forename: Mehmet
authors.initials: M
authors.lastname: Ceyhan
authors.forename: Güler
authors.initials: G
authors.lastname: Kanra
authors.forename: Münevver
authors.initials: M
authors.lastname: Büyükpamukçu
authors.forename: Gülten
authors.initials: G
authors.lastname: Seçmeer
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000175:diagnosis / Q000382:microbiology; D000077723:Cefepime; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D019348:Empiricism; D005260:Female; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D008297:Male; D000077731:Meropenem; D009369:Neoplasms / Q000150:complications; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D013810:Therapeutic Equivalency; D013845:Thienamycins / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013845:Thienamycins; D016179:Granulocyte Colony-Stimulating Factor; D000077723:Cefepime; D000077731:Meropenem